Literature DB >> 20483460

Increased risk of gout among patients with bipolar disorder: a nationwide population-based study.

Kuo-Hsuan Chung1, Chung-Chien Huang, Herng-Ching Lin.   

Abstract

This study aims to explore the association between bipolar disorder and the risk of gout using a nationwide population-based dataset. We used the 1996-2006 data from the Taiwan National Health Insurance Research Database. The study cohort comprised 24,262 patients who had visited outpatient departments for the treatment of bipolar disorder in the year 2000. A total of 121,310 enrollees matched with the study group in terms of age and gender, and were selected as the comparison cohort. Each patient was tracked 6 years from the index outpatient visit in 2000 until 2006 to identify all who had developed gout. Cox proportional hazard regressions were performed to compute the 6-year gout-free survival rate, adjusting for other variables. We found that gout occurred among 16.4% of the patients with bipolar disorder and 13.6% of the patients in the comparison cohort between 2000 and 2006 (P<0.001). After adjusting for potential confounders, the regression analysis shows that the hazard of developing gout during the 6-year follow-up period was 1.19 greater (95% confidence interval (CI)=1.10-1.24, P<0.001) for patients with bipolar disorder than their counterparts in the comparison cohort. We conclude that patients with bipolar disorder had increased risk of developing gout even after adjusting for possible confounding factors.
Copyright © 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20483460     DOI: 10.1016/j.psychres.2009.07.012

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

Review 1.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

Review 2.  Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.

Authors:  Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2011-02-24       Impact factor: 6.505

Review 3.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

Review 4.  Intracellular Signaling Cascades in Bipolar Disorder.

Authors:  Gregory H Jones; Carola Rong; Aisha S Shariq; Abhinav Mishra; Rodrigo Machado-Vieira
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 5.  Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications.

Authors:  Joshua D Rosenblat; Roger S McIntyre
Journal:  Brain Sci       Date:  2017-10-30

6.  Comparison of Serum Uric Acid in Major Depressive Disorder and Bipolar Disorder: a Retrospective Chart Review Study.

Authors:  Soomin Kim; Sang Jin Rhee; Yoojin Song; Yong Min Ahn
Journal:  J Korean Med Sci       Date:  2020-07-20       Impact factor: 2.153

7.  Metabolomic biomarkers related to non-suicidal self-injury in patients with bipolar disorder.

Authors:  Xiangjie Guo; Jiao Jia; Zhiyong Zhang; Yuting Miao; Peng Wu; Yaqin Bai; Yan Ren
Journal:  BMC Psychiatry       Date:  2022-07-22       Impact factor: 4.144

8.  High Risk of Depressive Disorders in Patients With Gout: A Nationwide Population-Based Cohort Study.

Authors:  Te-Chang Changchien; Yung-Chieh Yen; Cheng-Li Lin; Ming-Chia Lin; Ji-An Liang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

9.  Increased Serum C3 and Decreased UA in Patients of Bipolar Disorder in Chinese Han Population.

Authors:  Xiudeng Yang; Huai Tao; Ledong Xiao; Cunyan Li; Yamei Tang; Yong Liu
Journal:  Front Psychiatry       Date:  2018-08-21       Impact factor: 4.157

10.  Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study.

Authors:  Zhe Lu; Yingtan Wang; Guanglei Xun
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.